Low Dose Cyclosporine-A Therapy in Severe Aplastic Anaemia

Journal of Association of Physicians of India

Volumn 49, Issue OCT, 2001, Pages 966-969

  Rai, M ^b   Singh, V P ^b   Shukla, J ^a   Sundar, S ^b   Jha, V C ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; STANOZOLOL;

ADULT; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TIME;

ADMINISTRATION, ORAL; ADULT; ANABOLIC AGENTS; ANEMIA, APLASTIC; CHILD; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PROGNOSIS; STANOZOLOL; TIME FACTORS;

EID: 0035495954     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hinterberger Fischer M, Hocker P, Lechner K, et al. Oral Cyclosporine-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure. Eur J Haematol 1989; 43 : 136-42.
2. Marin P, Nomdedeu B, et al. Cyclosporine-A versus antilymphocyte globulin in severe aplastic anaemia. Br J Haematol 1989; 73 : 285.
3. Gluckman E, Esperou-Bourdeau H, Baruchel A, et al. Multicentre randomized study comparing Cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anaemia. Blood 1992; 79 : 2540-6.
4. Stryckmans PA, Dumont JP, Velu JH, et al. Cyclosporine in refractory severe aplastic anaemia. N Engl J Med 1984; 316 : 655.
5. Totterman TH, Hoglund M, Bengtsson M, et al. Treatment of pure red cell aplasia and aplastic anaemia with cyclosporine : Long term clinical effects. Eur J Haematol 1989; 42 : 126-33.
6. Leonard EM, Rafsky E, et al. Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol 1989; 72 : 278-84.
7. Camitta BM, Thomas ED, Nathan DG, et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anaemia. Blood 1979; 53 : 504-14.
8. Orosz GG, Roopenian DC, Widner MB, et al. Differential blockade of various cloned T cell functions by cyclosporine. Transplantation 1993; 36 : 706-11.
9. Bickel M, Tsuda H, Amstad P, et al. Differential regulation of colony-stimulating-factors and interleukin-2 production by Cyclosporine-A. Proceedings of the National Academy of Sciences of the United States of America. 1987; 84 : 3274-77.
10. Frikha M, Sahnoun Z, Kaabachi S, et al. Treatment of aplastic anaemia with cyclosporine, prednisone and androgens (primary results apropos of 10 cases). Therapie 1996; 51 : 627-9.
11. Bogacheva NIV, Shneider MM, Maschan AA, et al. "Cyclosporine dependence" in the treatment of severe aplastic anaemia in children. Gematol Transfuziol 1996; 41 : 18-21.
12. Davis S, Rubin AD, et al. Treatment and prognosis in aplastic anaemia. Lancet 1972; I : 871.
13. Sanchez-Medal L, Gomez-Leal A, Durate L. Anabolic androgenic steroids in the treatment of acquired aplastic anaemia. Blood 1969; 34 : 283.